DPAM
EW icon

Degroof Petercam Asset Management’s Edwards Lifesciences EW Stock Holding History

Degroof Petercam Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$86.2M Buy
901,982
+11,559
+1% +$971K 1.04% 22
2023
Q4 		$67.9M Buy
+890,423
New +$62M 0.89% 24

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Degroof Petercam Asset Management's EW Position: Q1 2024 in Review

Degroof Petercam Asset Management increased its Edwards Lifesciences (EW) stake by 1.3% in Q1 2024, buying an estimated $971K and bringing the position to 901,982 shares worth $86.2M. The position accounts for 1.04% of the portfolio, ranked #22.

Degroof Petercam Asset Management first reported a position in EW in Q4 2023 and has held it in 2 quarters since. 1,280 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • Degroof Petercam Asset Management held 901,982 shares of Edwards Lifesciences worth $86.2M as of Q1 2024.
  • Degroof Petercam Asset Management bought 11,559 Edwards Lifesciences shares in Q1 2024, an estimated $971K.
  • Edwards Lifesciences made up 1.04% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #22 holding.
  • Degroof Petercam Asset Management first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 2 quarters since.
  • 1,280 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.